These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 1396732)

  • 1. Differential effects of bismuth and salicylate salts on the antibiotic susceptibility of Pseudomonas aeruginosa.
    Domenico P; O'Leary R; Cunha BA
    Eur J Clin Microbiol Infect Dis; 1992 Feb; 11(2):170-5. PubMed ID: 1396732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduction of capsular polysaccharide and potentiation of aminoglycoside inhibition in gram-negative bacteria by bismuth subsalicylate.
    Domenico P; Landolphi DR; Cunha BA
    J Antimicrob Chemother; 1991 Dec; 28(6):801-10. PubMed ID: 1816178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activity of amoxicillin, metronidazole, bismuth salicylate and six aminoglycosides against Helicobacter pylori.
    Brenciaglia MI; Fornara AM; Scaltrito MM; Braga PC; Dubini F
    J Chemother; 1996 Feb; 8(1):52-4. PubMed ID: 8835109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative antimicrobial activity of FK037, cefpirome, ceftazidime and cefepime against aminoglycoside-sensitive and aminoglycoside-resistant Pseudomonas aeruginosa and Pseudomonas spp.
    Baltch AL; Smith RP; Ritz W
    Chemotherapy; 1994; 40(6):391-8. PubMed ID: 7842822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro antibacterial activity of bismuth subsalicylate.
    Cornick NA; Silva M; Gorbach SL
    Rev Infect Dis; 1990; 12 Suppl 1():S9-10. PubMed ID: 2305178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of sodium salicylate on antibiotic susceptibility and synergy in Klebsiella pneumoniae.
    Domenico P; Hopkins T; Cunha BA
    J Antimicrob Chemother; 1990 Sep; 26(3):343-51. PubMed ID: 2228825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Analysis of drug resistance of Pseudomonas aeruginosa and use of antibiotics in burn wards during 6 years].
    Dou Y; Zhang Q
    Zhonghua Shao Shang Za Zhi; 2014 Feb; 30(1):9-14. PubMed ID: 24684983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative in-vitro activities of newer cephalosporins cefclidin, cefepime, and cefpirome against ceftazidime- or imipenem-resistant Pseudomonas aeruginosa.
    Watanabe N; Hiruma R; Katsu K
    J Antimicrob Chemother; 1992 Nov; 30(5):633-41. PubMed ID: 1493980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The minimum inhibitory concentrations of various bismuth salts against Campylobacter pylori.
    Vogt K; Warrelmann M; Hahn H
    Zentralbl Bakteriol; 1989 Sep; 271(3):304-10. PubMed ID: 2803458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro susceptibility of Campylobacter pyloridis to cimetidine, sucralfate, bismuth and sixteen antibiotics.
    Andreasen JJ; Andersen LP
    Acta Pathol Microbiol Immunol Scand B; 1987 Apr; 95(2):147-9. PubMed ID: 3591312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of rifampicin on the in-vitro activity of cefpirome or ceftazidime in combination with aminoglycosides against Pseudomonas aeruginosa.
    Valdes JM; Baltch AL; Smith RP; Hammer MC; Ritz WJ
    J Antimicrob Chemother; 1990 Apr; 25(4):575-84. PubMed ID: 2112539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative in vitro activity of cefepime (BMY 28142) against multiresistant nosocomial isolates of Pseudomonas aeruginosa.
    Voutsinas D; Mavroudis T; Avlamis A; Giamarellou H
    Eur J Clin Microbiol Infect Dis; 1989 Oct; 8(10):917-9. PubMed ID: 2512141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does ivacaftor interfere with the antimicrobial activity of commonly used antibiotics against Pseudomonas aeruginosa?-Results of an in vitro study.
    Millar BC; Rendall JC; Downey DG; Moore JE
    J Clin Pharm Ther; 2018 Dec; 43(6):836-843. PubMed ID: 29959786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aminoglycosides plus beta-lactams against gram-negative organisms. Evaluation of in vitro synergy and chemical interactions.
    Giamarellou H
    Am J Med; 1986 Jun; 80(6B):126-37. PubMed ID: 3088998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro activity of piperacillin, ticarcillin, mezlocillin, ticarcillin-clavulanic acid, aztreonam, ceftazidime, azlocillin, cefoperazone, and thienamycin against Pseudomonas aeruginosa.
    Greenberg RN; Bollinger MR; Alivisatos MR
    Clin Ther; 1986; 8(6):655-7. PubMed ID: 3098426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Antimicrobial susceptibility of Pseudomonas aeruginosa isolated in Fukushima Prefecture].
    Niitsuma K; Saitoh M; Kojimabara M; Kashiwabara N; Aoki T; Tomizawa M; Maeda J; Kosenda T
    Jpn J Antibiot; 2001 Feb; 54(2):79-87. PubMed ID: 11338681
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transient carbapenem resistance induced by salicylate in Pseudomonas aeruginosa associated with suppression of outer membrane protein D2 synthesis.
    Sumita Y; Fukasawa M
    Antimicrob Agents Chemother; 1993 Dec; 37(12):2743-6. PubMed ID: 8109947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative in vitro activity of aztreonam, other beta-lactam antibiotics and aminoglycosides against Pseudomonas aeruginosa.
    Venditti M; Brandimarte C; Santini C; Valente B; Martino P; Serra P
    Chemioterapia; 1984 Aug; 3(4):258-61. PubMed ID: 6442625
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro activity of clarithromycin in combination with other antimicrobial agents against biofilm-forming Pseudomonas aeruginosa strains.
    Kádár B; Szász M; Kristóf K; Pesti N; Krizsán G; Szentandrássy J; Rókusz L; Nagy K; Szabó D
    Acta Microbiol Immunol Hung; 2010 Sep; 57(3):235-45. PubMed ID: 20870595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [E-test to study small inhibitor concentrations, bacterial diversity and to identify presumptively beta-lactamases in strains of Pseudomonas aeruginosa and Acinetobacter baumannii associated with +nosocomial infections].
    Triantafilo V; Fica A; Silva M; Thompson L
    Rev Med Chil; 1997 Feb; 125(2):149-60. PubMed ID: 9430934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.